DK705888A - Pyridazinonderivater - Google Patents

Pyridazinonderivater

Info

Publication number
DK705888A
DK705888A DK705888A DK705888A DK705888A DK 705888 A DK705888 A DK 705888A DK 705888 A DK705888 A DK 705888A DK 705888 A DK705888 A DK 705888A DK 705888 A DK705888 A DK 705888A
Authority
DK
Denmark
Prior art keywords
substd
opt
pyridazinone
derivs
ch2oh
Prior art date
Application number
DK705888A
Other languages
Danish (da)
English (en)
Other versions
DK705888D0 (da
Inventor
Rolf Herter
Peter Moersdorf
Volker Pfahlert
Heidrun Engler
Helmut Schickaneder
Kurt Henning Ahrens
Original Assignee
Heumann Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Pharma Gmbh & Co filed Critical Heumann Pharma Gmbh & Co
Publication of DK705888D0 publication Critical patent/DK705888D0/da
Publication of DK705888A publication Critical patent/DK705888A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK705888A 1988-02-12 1988-12-19 Pyridazinonderivater DK705888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3804490A DE3804490A1 (de) 1988-02-12 1988-02-12 Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
DK705888D0 DK705888D0 (da) 1988-12-19
DK705888A true DK705888A (da) 1989-08-13

Family

ID=6347332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK705888A DK705888A (da) 1988-02-12 1988-12-19 Pyridazinonderivater

Country Status (17)

Country Link
US (1) US4954501A (cs)
EP (1) EP0327800B1 (cs)
JP (1) JPH01246268A (cs)
KR (1) KR890012974A (cs)
AT (1) ATE76640T1 (cs)
AU (1) AU609922B2 (cs)
CA (1) CA1316535C (cs)
DE (2) DE3804490A1 (cs)
DK (1) DK705888A (cs)
ES (1) ES2042807T3 (cs)
GR (1) GR3004789T3 (cs)
HU (1) HU200337B (cs)
IE (1) IE62116B1 (cs)
IL (1) IL88784A (cs)
NZ (1) NZ227543A (cs)
PT (1) PT89468B (cs)
ZA (1) ZA889559B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2717687B2 (ja) * 1988-02-13 1998-02-18 日本曹達株式会社 ピリダジノン誘導体及びその製造方法
GB8824458D0 (en) * 1988-10-19 1988-11-23 Orion Yhtymae Oy Substituted pyridazinones
IL94394A (en) * 1989-05-17 1994-10-21 Nissan Chemical Ind Ltd History of pyridazinone, process for their preparation and preparations for controlling and / or preventing insects, mites, nematodes and mollusks
US5142021A (en) * 1990-10-19 1992-08-25 The Dow Chemical Company Use of reducing agents in polybenzazole synthesis
AU2002345796A1 (en) * 2001-06-26 2003-03-03 Beth Israel Deaconess Medical Center Compositions and methods for inhibiting platelet activation and thrombosis
WO2005000795A2 (en) * 2003-06-10 2005-01-06 Smithkline Beecham Corporation Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
DK1951227T3 (en) * 2005-11-14 2017-07-10 Boehringer Ingelheim Vetmedica Gmbh APPLICATION OF PIMOBENDAN TO TREAT ASYMPTOMATIC (OCCULT) HEART FAILURE
AU2007277163B2 (en) * 2006-07-25 2012-06-21 Cephalon, Inc. Pyridizinone derivatives
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
MX2011005444A (es) 2008-11-25 2011-06-09 Boehringer Ingelheim Vetmed Inhibidores de la fosfodiesterasa tipo iii (pde iii) o agentes sensibilizantes a iones de ca(2+) para el tratamiento de la cardiomiopatia hipertrofica.
HUE060093T2 (hu) 2012-03-15 2023-01-28 Boehringer Ingelheim Vetmedica Gmbh Gyógyszerészeti tablettakészítmény az állatgyógyászati ágazat számára, eljárás annak elõállítására és annak alkalmazása
WO2014164704A2 (en) * 2013-03-11 2014-10-09 The Broad Institute, Inc. Compounds and compositions for the treatment of cancer
EP3021832B9 (en) 2013-07-19 2023-03-15 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
EP3106150B1 (en) 2013-12-04 2021-07-28 Boehringer Ingelheim Vetmedica GmbH Improved pharmaceutical compositions of pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
WO2021217040A1 (en) * 2020-04-24 2021-10-28 Immvention Therapeutix Carbamate and urea derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37788A0 (en) * 1970-10-09 1971-12-29 American Cyanamid Co New pyridazinone compounds,their preparation and pharmaceutical compositions containing them
US4088762A (en) * 1971-02-22 1978-05-09 Bdh Pharmaceuticals Limited 6-(P-PIPERAZINO)-PHENYL-4,5-DIHYDRO-3(2H)pyridazinones
GB1383906A (en) * 1971-02-22 1974-02-12 Bdh Pharmaceuticals Ltd Pyridazinones
DE2837161A1 (de) * 1978-08-25 1980-03-06 Thomae Gmbh Dr K Neue benzimidazole und deren verwendung
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
JPS58113180A (ja) * 1981-12-28 1983-07-05 Mitsui Toatsu Chem Inc ピリダジノン誘導体
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
US4584299A (en) * 1984-05-21 1986-04-22 Warner-Lambert Company Method of treating heart failure and medicaments therefor
DE3425632A1 (de) * 1984-07-12 1986-01-16 Basf Ag, 6700 Ludwigshafen (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung
JPS6153270A (ja) * 1984-08-17 1986-03-17 チバ・ガイギー・アクチエンゲゼルシヤフト 置換ピリダジノン、その製造方法及び該化合物を含む医薬製剤
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー 4,5‐ジヒドロ‐4,4‐ジアルキル‐6‐(置換)フエニル‐3(2h)‐ピリダジノン類
JPS62298820A (ja) * 1986-06-18 1987-12-25 Omron Tateisi Electronics Co 座標入力装置
JPS648666A (en) * 1987-06-30 1989-01-12 Sharp Kk Contact type image sensor
DE3728491A1 (de) * 1987-08-26 1989-03-09 Heumann Pharma Gmbh & Co Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH046570A (ja) * 1990-04-25 1992-01-10 Toshiba Corp 画像形成装置

Also Published As

Publication number Publication date
HUT49349A (en) 1989-09-28
NZ227543A (en) 1990-04-26
DE3804490A1 (de) 1989-08-24
HU200337B (en) 1990-05-28
DE58901510D1 (de) 1992-07-02
AU2758088A (en) 1989-08-17
CA1316535C (en) 1993-04-20
US4954501A (en) 1990-09-04
GR3004789T3 (cs) 1993-04-28
PT89468B (pt) 1993-12-31
ES2042807T3 (es) 1993-12-16
ATE76640T1 (de) 1992-06-15
IE62116B1 (en) 1994-12-14
PT89468A (pt) 1990-03-08
EP0327800B1 (de) 1992-05-27
EP0327800A3 (en) 1990-04-11
DK705888D0 (da) 1988-12-19
IL88784A0 (en) 1989-07-31
IL88784A (en) 1993-05-13
JPH01246268A (ja) 1989-10-02
EP0327800A2 (de) 1989-08-16
AU609922B2 (en) 1991-05-09
ZA889559B (en) 1989-09-27
IE883823L (en) 1989-08-12
KR890012974A (ko) 1989-09-20

Similar Documents

Publication Publication Date Title
DK705888D0 (da) Pyridazinonderivater
ATE157368T1 (de) 6-0-methylerythromycin a-derivat
DE3867572D1 (de) Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel.
DE3879264D1 (de) N-substituierte azole.
DE3861484D1 (de) Indanamin-derivate als antiarrhythmische mittel.
PL312528A1 (en) Novel substituted derivatives benzene sulphonylurea and benzene thiosulpholylurea, method of obtaining them, their application in production of therapeutic or diagnostic agents and pharmaceutic agents as such
PT737678E (pt) Derivados 4-indolilpiperazinilo
ATE90685T1 (de) Disaccharidderivate.
EE9600114A (et) Asendatud 4H-püraanid
EE9500076A (et) 1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena
ATE194140T1 (de) Thiophenverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen
DE3660426D1 (de) Urea acryl derivatives
DE59002904D1 (de) Cyclopropanthiocarbonsaeureamide.
ATE163005T1 (de) Saintopin derivate
ES8801125A1 (es) Procedimiento para la obtencion de medicamentos antiasmaticos que comprenden 5-sulfonil-1,4-dihidropiridinas como principio activo.
ES8800930A1 (es) Un metodo de preparacion de un compuesto de oxodiazina
ES2152459T3 (es) Aminopiranos sustituidos con acilo con actividad moduladora sobre canales de potasio.
ATE49598T1 (de) Antiarrhythmische mittel.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment